Skip to main content

Advertisement

Log in

Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume Center

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Purpose

To investigate the short-term outcomes and long-term oncological efficacy of video-assisted thoracic surgery (VATS) for surgical treatment of pN2 non-small cell lung cancer (NSCLC) compared with open thoracotomy (OT).

Patients and methods

We retrospectively collected data from 1034 patients who underwent pulmonary resection and systemic lymph node dissection for pathological N2 NSCLC from September 2005 to December 2017 (536 patients in VATS group and 498 patients in OT group). Propensity score matching was applied to reduce the confounding effects. Factors affecting survival were assessed by Kaplan–Meier estimates and Cox regression analysis.

Results

The VATS procedure was associated with shorter operative time compared with the OT procedure (147.96 ± 58.91 min vs. 165.34 ± 58.91 min, P < 0.001). No significant difference was identified between the two groups in the number of dissected mediastinal lymph nodes (MLNs) and number of dissected MLNs stations. More patients after VATS procedure received postoperative adjuvant therapy (83.4% vs. 75.5%, P = 0.002). At a median follow-up of 36 (range 4–150) months, comparing VATS procedure and OT procedure, no significant differences were noted in 5-year DFS (20.7% vs. 22.5%, P = 0.89) and 5-year OS (30.7% vs. 34.5%, P = 0.821). The VATS procedure was not found to be an independent predictor of DFS (hazard ratio, 0.986; 95% CI, 0.809 to 1.202) or OS (hazard ratio, 0.977; 95% CI 0.802 to 1.191).

Conclusion

In this large propensity-matched comparison, the VATS procedure offered comparable short-term outcomes and long-term oncological efficacy for patients with pN2 NSCLC when compared with OT procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Asamura H, Chansky K, Crowley J et al (2015) The International Association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10:1675–1684

    CAS  PubMed  Google Scholar 

  2. Ramnath N, Dilling TJ, Harris LJ et al (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e314S–e340

    CAS  PubMed  Google Scholar 

  3. Eberhardt WE, De Ruysscher D, Weder W et al (2015) 2nd ESMO consensus conference in lung cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 26:1573–1588

    CAS  PubMed  Google Scholar 

  4. Zhao Y, Wang W, Liang H et al (2019) The optimal treatment for stage IIIA-N2 non-small cell lung cancer: a network meta-analysis. Ann Thorac Surg 107:1866–1875

    PubMed  Google Scholar 

  5. Decaluwe H, De Leyn P, Vansteenkiste J et al (2009) Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Eur J Cardiothorac Surg 36:433–439

    PubMed  Google Scholar 

  6. Cerfolio RJ, Maniscalco L, Bryant AS (2008) The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg 86:912–920 (discussion 20)

    PubMed  Google Scholar 

  7. Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y (2008) Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur J Cardiothorac Surg 34:187–195

    PubMed  Google Scholar 

  8. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W (2002) A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36:1–6

    PubMed  Google Scholar 

  9. Yan TD, Black D, Bannon PG, McCaughan BC (2009) Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 27:2553–2562

    PubMed  Google Scholar 

  10. Paul S, Altorki NK, Sheng S et al (2010) Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 139:366–378

    PubMed  Google Scholar 

  11. Cao C, Zhu Z-H, Yan TD et al (2013) Video-assisted thoracic surgery versus open thoracotomy for non-small-cell lung cancer: a propensity score analysis based on a multi-institutional registry. Eur J Cardiothorac Surg 44:849–854

    PubMed  Google Scholar 

  12. Falcoz PE, Puyraveau M, Thomas PA et al (2016) Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg 49:602–609

    PubMed  Google Scholar 

  13. Bendixen M, Jorgensen OD, Kronborg C, Andersen C, Licht PB (2016) Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol 17:836–844

    PubMed  Google Scholar 

  14. Yang CJ, Kumar A, Klapper JA et al (2019) A national analysis of long-term survival following thoracoscopic versus open lobectomy for stage I non-small-cell lung cancer. Ann Surg 269:163–171

    PubMed  Google Scholar 

  15. Yang CJ, Kumar A, Deng JZ et al (2019) A national analysis of short-term outcomes and long-term survival following thoracoscopic versus open lobectomy for clinical stage II non-small-cell lung cancer. Ann Surg. https://doi.org/10.1097/SLA.0000000000003231

    Article  PubMed  PubMed Central  Google Scholar 

  16. Boffa DJ, Kosinski AS, Furnary AP et al (2018) Minimally invasive lung cancer surgery performed by thoracic surgeons as effective as thoracotomy. J Clin Oncol 36:2378–2385

    CAS  PubMed  Google Scholar 

  17. Watanabe A, Mishina T, Ohori S et al (2008) Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer? Eur J Cardiothorac Surg 33:812–818

    PubMed  Google Scholar 

  18. Li Y, Wang J (2012) Comparison of clinical outcomes for patients with clinical N0 and pathologic N2 non-small cell lung cancer after thoracoscopic lobectomy and open lobectomy: a retrospective analysis of 76 patients. J Surg Oncol 106:431–435

    PubMed  Google Scholar 

  19. Zhong C, Yao F, Zhao H (2013) Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer. Ann Thorac Surg 95:987–992

    PubMed  Google Scholar 

  20. Boffa DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M (2012) Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg 94:347–353 (discussion 53)

    PubMed  Google Scholar 

  21. Licht PB, Jorgensen OD, Ladegaard L, Jakobsen E (2013) A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg 96:943–949 (discussion 9–50)

    PubMed  Google Scholar 

  22. Medbery RL, Gillespie TW, Liu Y et al (2016) Nodal upstaging is more common with thoracotomy than with VATS during lobectomy for early-stage lung cancer: an analysis from the national cancer data base. J Thorac Oncol 11:222–233

    PubMed  PubMed Central  Google Scholar 

  23. Martin JT, Durbin EB, Chen L et al (2016) Nodal upstaging during lung cancer resection is associated with surgical approach. Ann Thorac Surg 101:238–244 (discussion 44–5)

    PubMed  Google Scholar 

  24. Hancock J, Rosen J, Moreno A, Kim AW, Detterbeck FC, Boffa DJ (2014) Management of clinical stage IIIA primary lung cancers in the National Cancer Database. Ann Thorac Surg 98:424–432 (discussion 32)

    PubMed  Google Scholar 

  25. Liu L, Che G, Pu Q et al (2010) A new concept of endoscopic lung cancer resection: single-direction thoracoscopic lobectomy. Surg Oncol 19:e71–e77

    PubMed  Google Scholar 

  26. Liu C, Pu Q, Guo C et al (2015) Non-grasping en bloc mediastinal lymph node dissection for video-assisted thoracoscopic lung cancer surgery. BMC Surg 15:38

    PubMed  PubMed Central  Google Scholar 

  27. Depierre A, Milleron B, Moro-Sibilot D et al (2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20:247–253

    PubMed  Google Scholar 

  28. van Meerbeeck JP, Kramer GW, Van Schil PE et al (2007) Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99:442–450

    PubMed  Google Scholar 

  29. Tanner NT, Gomez M, Rainwater C et al (2012) Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol 7:365–369

    PubMed  PubMed Central  Google Scholar 

  30. Yoshino I, Yoshida S, Miyaoka E et al (2012) Surgical outcome of stage IIIA-cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol 7:850–855

    PubMed  Google Scholar 

  31. Boffa DJ, Hancock JG, Yao X et al (2015) Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database. Ann Thorac Surg 99:200–208

    PubMed  Google Scholar 

  32. Rami-Porta R, Wittekind C, Goldstraw P, International Association for the Study of Lung Cancer Staging C (2005) Complete resection in lung cancer surgery: proposed definition. Lung Cancer 49:25–33

    PubMed  Google Scholar 

  33. Detterbeck F (2008) What to do with "surprise" N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 3:289–302

    PubMed  Google Scholar 

  34. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y (1999) The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 118:145–153

    CAS  PubMed  Google Scholar 

  35. Watanabe A, Miyajima M, Mishina T et al (2017) Video-assisted thoracoscopic surgery node dissection for lung cancer treatment. Surg Today 47:1419–1428

    PubMed  Google Scholar 

  36. Merritt RE, Hoang CD, Shrager JB (2013) Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg 96:1171–1177

    PubMed  Google Scholar 

  37. Martin JT, Durbin EB, Chen L et al (2015) Nodal upstaging during lung cancer resection is associated with surgical approach. Ann Thorac Surg 101:238–244 (discussion 44–5)

    PubMed  PubMed Central  Google Scholar 

  38. Zhang W, Wei Y, Jiang H, Xu J, Yu D (2016) Video-assisted thoracoscopic surgery versus thoracotomy lymph node dissection in clinical stage I lung cancer: a meta-analysis and system review. Ann Thorac Surg 101:2417–2424

    PubMed  Google Scholar 

  39. Jeon YJ, Choi YS, Lee KJ, Lee SH, Pyo H, Choi JY (2018) Outcomes of pulmonary resection and mediastinal node dissection by video-assisted thoracoscopic surgery following neoadjuvant chemoradiation therapy for stage IIIA N2 non-small cell lung cancer. Korean J Thorac Cardiovasc Surg 51:29–34

    PubMed  PubMed Central  Google Scholar 

  40. Tian Z, Sui X, Yang F, Wang J (2019) Is video-assisted thoracoscopy a sufficient approach for mediastinal lymph node dissection to treat lung cancer after neoadjuvant therapy? Thorac Cancer 10:782–790

    PubMed  PubMed Central  Google Scholar 

  41. Seder CW, Salati M, Kozower BD et al (2016) Variation in pulmonary resection practices between The Society of Thoracic Surgeons and the European Society of Thoracic surgeons general thoracic surgery databases. Ann Thorac Surg 101:2077–2084

    PubMed  Google Scholar 

  42. Rusch VW, Asamura H, Watanabe H et al (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4:568–577

    PubMed  Google Scholar 

Download references

Funding

This study is supported by the Basic Science Program (2019YJ0077 to Chengwu Liu), Science & Technology Department of Sichuan Province, and the 1.3.5 Project for Disciplines of Excellence (ZYJC18009 to Jiandong Mei, and ZYGD18021 to Lunxu Liu), West China Hospital, Sichuan University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lunxu Liu.

Ethics declarations

Disclosures

Drs. Chengwu Liu, Chenglin Guo, Fanyi Gan, Jiandong Mei, Qiang Pu, Zheng Liu, Yunke Zhu, Hu Liao, Lin Ma, Feng Lin, and Lunxu Liu have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, C., Guo, C., Gan, F. et al. Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume Center. Surg Endosc 35, 2186–2197 (2021). https://doi.org/10.1007/s00464-020-07624-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07624-2

Keywords

Navigation